SEC Form 4 · accession 0001140361-15-004967
Achaogen, Inc. · AKAO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian Friedland
Officer — Chief Medical Officer
Period of report
Feb 5, 2015
Accepted (ET)
Feb 9, 2015 · 9:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001301501
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 5, 2015 | A | 15,000 | $0.00 | A | 15,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $11.78 | Feb 5, 2015 | A | 51,500 | A | — | Feb 5, 2025 | Common Stock | 51,500 | 51,500 | D |
Explanation of responses
- F1Restricted Stock Units ("RSUs"). The reporting person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.
- F2The shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of March 11, 2015, subject to the reporting person's continued employment or service relationship with the Issuer on each such vesting date.